Repeated cardiac pacing extends the time during which canine hearts are protected against ischaemia-induced arrhythmias: Role of nitric oxide

Journal of Molecular and Cellular Cardiology

Volumn 31, Issue 6, 1999, Pages 1229-1241

  Kis, Adrienn ^a   Végh, Ágnes ^a   Papp, Julius Gy ^a   Parratt, James R ^a,b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Aminoethylisothiourea; Arrhythmias; Cardiac pacing; Ischaemia; Nitric oxide

Indexed keywords

AMINOETHYLISOTHIOURONIUM; NITRIC OXIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PACING; HEART PROTECTION; HEART RIGHT VENTRICLE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; ST SEGMENT;

EID: 0033152886     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1999.0955     Document Type: Article

References (42)

1. Baxter GF, Goma FM, Yellon DM, 1995. Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardium. Br J Pharmacol 115: 222-224.
2. Baxter GF, Marber MS, Patel VC, Yellon DM, 1994. Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning. Circulation 90: 2993-3000.
3. Bolli R, Bhatti ZA, Tang X-L, Qiu Y, Zhang Q, Guo Y, Jadoon AK, 1997. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res 81: 42-52.
4. Egashira K, Katsuda Y, Mohri M, Kuga T, Tagawa T, Kubota T, Hirakawa Y, Takeshita A, 1996. Role of endothelium-derived nitric oxide in coronary vasodilatation induced by pacing tachycardia in humans. Circ Res 79: 331-335.
5. Ferdinandy P, Szilvassy Z, Baxter GF, 1998. Adaptation to myocardial stress in disease states: Is preconditioning a healthy heart phenomenon? Trends Pharmacol Sci 19: 223-229.
6. Hull SS, Vanoli E, Adamson PB, Verrier RL, Foreman RD, Schwartz PJ, 1994. Exercise training confers anticipatory protection from sudden death during acute myocardial ischemia. Circulation 89: 548-552.
7. Julou-Schaeffer G, Gray GA, Fleming I, SChott C, Parratt JR, Stoclet JC, 1990. Loss of vascular responsiveness induced by endotoxin involves the L-arginine pathway. Am J Physiol 259: H1038-H1043.
8. Kaszala K, Végh Á, Papp JGy, Parratt JR, 1996. Time course of the protection against ischaemia and reperfusion-induced ventricular arrhythmias resulting from brief periods of cardiac pacing. J Mol Cell Cardiol 28: 2085-2095.
9. Kis A, Végh Á, Papp JGy, Parratt JR, 1996. Repeated cardiac pacing prolongs protection against ischaemia-induced ventricular arrhythmias (abstract). J Mol Cell Cardiol 28: A229.
10. Kis A, Végh Á, Papp JGy, Parratt JR, 1998a. Pacing-induced delayed antiarrhythmic protection in dogs is attenuated by aminoguanidine (abstract). J Mol Cell Cardiol 30: A72.
11. Kis A, Végh Á, Papp JGy, Parratt JR, 1998b. Repeated cardiac pacing prolongs protection against ischemia-induced ventricular arrhythmias in anaesthetised dogs (abstract). J Physiol 505: 56P.
12. ATP channels. Circulation 93: 178-186.
13. Kuzuya T, Hoshida S, Yamashita N, Fuji H, Oe H, Hori M, Kamada T, Tada M, 1993. Delayed effect of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 72: 1293-1299.
14. Lee IM, Hsieh CC, Paffenbarger RS, 1995. Exercise intensity and longevity in men. The harvard alumni health study. JAMA 273: 1179-1184.
15. Marber MS, Latchman DS, Walker JM, Yellon DM, 1993. Cardiac stress protein elevation 20 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 88: 1264-1272.
16. Matsumoto A, Hirata Y, Momomura S-I, Fujita H, Yao A, Sata M, Serizawa T, 1994. Increased nitric oxide production during exercise. Lancet 343: 849-850.
17. Mittleman MA, Maclurf M, Tofler GH, Sherwood JB, Goldberg RJ, Muller JE, 1993. Triggering of acute myocardial infarction by heavy physical exertion. N Engl J Med 329: 1677-1683.
18. Murry CE, Jennings RB, Reimer KA, 1986. Preconditioning with ischaemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136.
19. Parratt JR, Szekeres L, 1995. Delayed protection of the heart against ischaemia. Trends Pharmacol Sci 16: 351-355.
20. Parratt JR, Végh Á, 1997a. Delayed protection against ventricular arrhythmias by cardiac pacing. Heart 78: 423-425.
21. Parratt JR, Végh Á, 1997b. Coronary vascular endothelium, preconditioning and arrhythmogenesis. In: Lewis MJ and Shah AM (eds). Endothelial Modulation of Cardiac Function. Harwood Academic Publishers, 237-255.
22. Southan GJ, Szabo C, Thiemermann C, 1995. Isothioureas: Potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br J Pharmacol 114: 510-516.
23. Southan GJ, Zingarelli B, O'Connor M, Salzman AL, Szabó C, 1996. Spontaneous rearrangement of amino-alkylisothioureas into merkaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform. Br J Pharmacol 117: 619-632.
24. Szekeres L, Papp JGy, Szilvassy Z, Udvary E, Végh Á, 1993. Moderate stress by cardiac pacing may induce both short term and long term cardioprotection. Cardiovasc Res 27: 593-596.
25. Szilvássy Z, Ferdinandy P, Bor P, Jakab I, Lonovics J, Koltai M, 1994. Ventricular overdrive pacing-induced anti-ischemic effect: A conscious rabbit model of preconditioning. Am J Physiol 266: H2033-H2041.
26. Szilvássy Z, Ferdinandy P, Nagy I, Jakab I, Koltai M, 1997. The effect of continuous versus intermittent treatment with transdermal nitroglycerin on pacing-induced preconditioning in conscious rabbits. Br J Pharmacol 121: 491-497.
27. Tofler GH, Mittleman MA, Muller JE, 1996. Physical activity and triggering of myocardial infarction: The case for regular exercise [editorial]. Heart 75: 323-325.
28. Végh Á, Szekeres L, Parratt JR, 1992a. Preconditioning of the ischaemic myocardium; involvement of the l-arginine-nitric oxide pathway. Br J Pharmacol 107: 648-652.
29. Végh Á, Komori S, Szekeres L, Parratt JR, 1992b. Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats. Cardiovasc Res 26: 486-495.
30. Végh Á, Papp JGy, Parratt JR, 1994. Prevention by dexamethasone of the marked antiarrhythmic effects of preconditioning induced 20 h after rapid cardiac pacing. Br J Pharmacol 113: 1081-1082.
31. Végh Á, Szekeres L, Parratt JR, 1991. Transient ischaemia induced by rapid cardiac pacing results in myocardial preconditioning. Cardiovasc Res 25: 1051-1053.
32. Walker MJA, Curtis MJ, Hearse DJ, Campbell RWF, Janse MJ, Yellon DM, Cobbe SM, Coker SJ, Harness JB, Harron DWG, Higgins AJ, Julian DG, Lab MJ, Manning AS, Northover BJ, Parratt JR, Riemersma RA, Riva E, Russell DC, Sheridan DJ, Winslow E, Woodward B, 1988. The Lambeth Conventions: Guidelines for the study of arrhythmias in ischaemia, and reperfusion. Cardiovasc Res 22: 447-455.
33. Williams DO, Scherlag BJ, Hope RR, El-Sherif N, Lazzara R, 1974. The pathophysiology of malignant ventricular arrhythmias during acute myocardial ischemia. Circulation 50: 1163-1172.
34. Willich SN, Lewis M, Lowel H, Arntz H-R, Schubert F, Schroder R, 1993. Physical exertion as a trigger of acute myocardial infarction. N Engl J Med 329: 1684-1690.
35. Wolfárd A, Kaszaki J, Szabo C, Balog Z, Nagy S, 1997a. Effects of nitric oxide synthase inhibition on the hemodynamic changes in hyperdynamic endotoxemia (abstract). Acta Chir Hung 36: 393-394.
36. Wolfárd A, Kaszaki J, Szabo C, Balog Z, Nagy S, 1997b. Effects of nitric oxide synthase inhibition on the hemodynamic changes in hyperdynamic endotoxemia (abstract). Shock 8: A158.
37. Wu S, Furman BL, Parratt JR, 1994. Attenuation by dexamethasone of endotoxin protection against ischemia induced ventricular arrhythmias. Br J Pharmacol 113: 1083-1084.
38. Wu S, Furman BL, Parratt JR, 1996. Delayed protection against ischaemia-induced ventricular arrhythmias and infarct size limitation by the prior administration of Escherichia coli endotoxin. Br J Pharmacol 118: 2157-2163.
39. Wu S, Furman BL, Parratt JR, 1998. Monophosphoryl lipid a reduces both arrhythmia severity and infarct size in a rat model of ischaemia. Eur J Pharmacol 345: 385-387.
40. Yamashita N, Kuzuya T, Hoshida S, Fuji H, Oe H, Kitabatake A, Tada M, Kamada T, 1992. Relationship between time interval from preconditioning to sustained ischemia and its effect of limiting infarct size. J Mol Cell Cardiol 24 (Suppl. 1): S150.
41. Yang X-M, Baxter GF, Heads RJ, Yellon DM, Downey JM, Cohen MV, 1996. Infarct limitation of the second window of protection in a conscious rabbit model. Cardiovasc Res 31: 777-783.
42. Yellon DM, Baxter GF, 1995. A "second window of protection" or delayed preconditioning phenomenon: Future horizons for myocardial protection? J Mol Cell Cardiol 27: 1023-1034.